OMAHA (DTN) -- Bayer Group has announced the company is consolidating its Roundup business into a new subsidiary, Ruveon LLC, which will oversee all aspects of the company's glyphosate business.

Ruveon will focus on all aspects of U.S. glyphosate -- pricing, go-to-market strategies, production and logistics -- and will be solely responsible for the U.S. glyphosate business. Ruveon is based in St. Louis, Missouri, and remains a Bayer Group business, Bayer stated in a news release.

The move comes just a week after Bayer won a major victory in the U.S. Supreme Court, which ruled that federal law preempts state failure-to-warn laws, effectively declaring Bayer is not required to provide a cancer warning for glyphosate products because the EPA has not required one.

Bayer also cited Ruveon as a subsidiary and one of the petitioners to the International Trade Commission earlier this week in its filing seeking antidumping and countervailing duties against glyphosate imports.

Bayer stated the consolidation of its U.S. glyphosate business "is an exceptional step for the company's Crop Science division and part of a five-year framework to boost growth and profitability and allow an even sharper focus on innovation and business operations." Bayer stated, "Ruveon is expected to be a more nimble and well-positioned player within its commodity-based market, which requires a specialized approach to address competitive dynamics."

"Today we take an important step within our Five-Year Framework," said Brian Naber, head of Crop Science North America & Australia/New Zealand. "Ruveon's launch is a sign of our ongoing commitment to excellence in the glyphosate market. Consolidating U.S. glyphosate resources and operations benefits customers, partners and other stakeholders by enabling the Ruveon and Bayer Group teams to fully dedicate the appropriate focus and resources to best meet and anticipate our respective customers' needs."

Bayer's stock on Thursday was up more than 8% to just over $15 a share. Since last week's Supreme Court decision, Bayer's stock has gone up by $2 a share.

Reuters cited stock analysts Thursday, speculating the move could set up Bayer to spin off or divest from its glyphosate business to avoid further litigation.

Bayer/Monsanto is the only U.S. manufacturer of glyphosate and produces roughly 60% of glyphosate sold in the U.S. and 40% of global sales. Last year, when Bayer executives warned they could discontinue selling Roundup because of the non-Hodgkin's lymphoma lawsuits, Bayer reported glyphosate generated $2.4 billion in revenue in 2024.

Bayer's move follows Corteva Agriscience splitting off its seed and herbicide businesses as well. Corteva has named its seed business Vylor Inc., while Corteva will remain the name for the crop-protection company.

Bayer also stated Alfonso Alba Ordonez is joining Ruveon as the company's CEO.

For more, see "Bayer Wins Big: SCOTUS Blocks State Lawsuits Over Roundup Cancer Warnings" here: https://www.dtnpf.com/….

And also see "Farmer Leaders Angry After Bayer/Monsanto Moves to Place Duties on Imported Glyphosate" here:

https://www.dtnpf.com/….

Chris Clayton can be reached at Chris.Clayton@dtn.com

Follow him on social platform X @ChrisClaytonDTN

(c) Copyright 2026 DTN, LLC. All rights reserved.